A.V. Palekhov (1, 2), E.S. Vvedenskaya (3)
MODERN REALITIES AND POTENTIALS FOR THE USE OF STRONG OPIOID ANALGESICS IN RUSSIA
|
5-11 |
I.M. Marusenko
EXPERIENCE OF THE USE OF GENETICALLY ENGINEERED BIOLOGIC DRUGS IN THE TREATMENT OF RHEUMATOID ARTHRITIS AFTER TOFACITINIB
|
12-14 |
I.A. Zolotovskaya (1), I.L. Davydkin (1), N.Yu. Borovkova (2)
THERAPY WITH NONSTEROID ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH ACUTE NONSPECIFIC LOW BACK PAIN: DYNAMICS OF RENAL FUNCTION: RESULTS OF “PANDA” COGORT STUDY
|
16-24 |
P.S. Kovalenko, I.S. Dydykina, A.V. Smirnov, S.I. Glukhova, L.I. Alekseeva, E.L. Nasonov
THE EXPERIENCE OF THE USE OF DENOSUMAB IN THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS WITH OSTEOPOROSIS
|
25-29 |
E.N. Sukhikh, O.V. Simonova
CONCENTRATIONS OF STABLE METABOLITES OF NITRIC OXIDE IN THE SERUM AND URINE OF PATIENTS WITH ANKILOSING SPONDYLOARTHRITIS
|
30-33 |
I.Z. Gaidukova, E.V. Khondkaryan, A.V. Aparkina, A.P. Rebrov
COMPARATIVE EFFICACY AND SAFETY OF THREE MODES FOR USE OF NONSTEROID ANTI-INFLAMMATORY DRUGS FOR THE TREATMENT OF CHRONIC BACK PAIN
|
34-39 |
N.G. Kashevarova, L.I. Alekseeva, E.A. Taskina, A.V. Smirnov
LEADING FACTORS FOR PROGRESSION OF OSTEOARTHRITIS OF THE KNEE. EFFECTS OF SYMPTOMATIC SLOW RELEASE PREPARATIONS ON THE COURSE OF THE DISEASE (5-YEAR PROSPECTIVE STUDY)
|
40-45 |
E.P. Sharapova, N.G. Kashevarova, E.A. Taskina, S.G. Anikin, T.A. Korotkova, L.I. Alekseeva
EVALUATION OF THE EFFICACY, TOLERABILITY AND SAFETY OF CHONDROGARD IN PATIENTS WITH OSTEOARTHROSIS OF THE KNEE AND COMORBIDITY
|
46-51 |
O.V. Simonova, E.A. Leushina, E.N. Sukhikh, M.V. Timin
INFLUENCE OF SYMPTOMATIC SLOW RELEASE PREPARATIONS ON QUALITY OF LIFE OF PATIENTS WITH Osteoarthrosis OF JOINTS OF THE HAND
|
52-55 |
R. Bektoshev, M. Ergashev, U.U. Zhumayev, O. Bektoshev, R. Usmonov, Sh. Bektoshev
IMMUNOSTIMULATING PREPARATIONS OF BACTERIAL ORIGIN IN THE COMPLEX OF CONCERVATIVE TREATMENT OF LUMBARY OSTEOCHONDROSIS
|
56-58 |
A.A. Karavashkina (1), I.V. Tsoy (2), M.N. Dadasheva (2)
APPLICATION OF ANTIPLATELETS IN CEREBROVASCULAR DISEASE
|
59-63 |